Document Detail


Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro.
MedLine Citation:
PMID:  15523693     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Investigations of the mechanisms of the cancer-preventive activity of apigenin (4',5,7,-trihydroxyflavone), a plant-derived, anti-carcinogenic flavonoid, showed its interference with cell proliferation, survival, and gap junctional coupling. We used a model based on non-invasive HeLa wild-type cells and their connexin43 (Cx43) transfected counterparts to correlate the effect of apigenin on tumour cell invasiveness with its influence on cell motility. Both cell lines displayed similar motile properties in control conditions. Apigenin treatment resulted in a significant and reversible inhibition of translocation of both HeLa wild-type cells and HeLa Cx43 transfectants. The effect of apigenin on cell proliferation was less pronounced especially at low apigenin concentration, whereas its influence on cell motility correlated with the reduction of the invasive potential of HeLa Cx43 cells as shown by an invasion assay based on the confrontation of tumour cell spheroids with chick embryo heart fragments. HeLa Cx43 cells were highly invasive in controls, but did not invade the heart tissue at tumour cell aggregate-fibroblast capsule interfaces in the presence of apigenin and failed to fully engulf these heart fragments. Because the motility of chick heart fibroblasts was only slightly affected by apigenin, these observations indicate that apigenin exerts its anti-invasive effect on HeLa cells predominantly via a specific inhibition of tumour cell motility. This inhibitory effect of apigenin on tumour cell invasiveness in vitro demonstrates that apigenin may exert its anti-tumorigenic effect in vivo via inhibition of tumour cell penetration of the healthy tissue.
Authors:
Jaroslaw Czyz; Zbigniew Madeja; Uwe Irmer; Wlodzimierz Korohoda; Dieter F Hülser
Related Documents :
15355933 - Rantes (ccl5) induces a ccr5-dependent accelerated shedding of syndecan-1 (cd138) and s...
21036023 - Ganoderic acid mf and s induce mitochondria mediated apoptosis in human cervical carcin...
6774693 - Fine structural features of secretion in adenomas of human pituitary gland.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International journal of cancer. Journal international du cancer     Volume:  114     ISSN:  0020-7136     ISO Abbreviation:  Int. J. Cancer     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-01-26     Completed Date:  2005-02-25     Revised Date:  2007-07-24    
Medline Journal Info:
Nlm Unique ID:  0042124     Medline TA:  Int J Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  12-8     Citation Subset:  IM    
Affiliation:
Department of Biophysics, Biological Institute, University of Stuttgart, Germany. JARO@mol.uj.edu.pl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / pharmacology*
Apigenin / pharmacology*
Cell Movement / drug effects
Cell Proliferation / drug effects
Connexin 43 / genetics
Dose-Response Relationship, Drug
Gap Junctions / drug effects
Hela Cells / drug effects
Humans
Neoplasm Invasiveness / prevention & control*
Time Factors
Transfection
Translocation, Genetic / drug effects*
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Connexin 43; 520-36-5/Apigenin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory ...
Next Document:  Genotype phenotype correlations in Israeli colorectal cancer patients.